Age: 80.0
Sex: F
Vaccine: VARZOS
Symptoms: Asthenia, Cough, Haemoptysis, Malaise, Pyrexia
Clinical narrative: feels very yucky; congestion; Diagnosed with RSV; sniffling; coughing; sneezing; mucous and blood; low grade fever; constant cough and force that was causing the bleeding; zapped her energy; This non-serious case was reported by a consumer and described the occurrence of respiratory syncytial virus infection in a 80-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included interstitial lung disease (diagnosed over 6 years ago). Concomitant products included guaifenesin (Mucinex).   In JUL-2023, the patient received Shingrix. On 29-NOV-2023, between 3 and 5 months after receiving Shingrix, the patient experienced respiratory syncytial virus infection (Verbatim: Diagnosed with RSV), sniffles (Verbatim: sniffling), cough (Verbatim: coughing), sneezing (Verbatim: sneezing), bloody discharge (Verbatim: mucous and blood), low grade fever (Verbatim: low grade fever), coughing blood (Verbatim: constant cough and force that was causing the bleeding) and energy decreased (Verbatim: zapped her energy). On an unknown date, the patient experienced feels awful (Verbatim: feels very yucky) and respiratory tract congestion (Verbatim: congestion). The outcome of the respiratory syncytial virus infection, sniffles, cough, sneezing, bloody discharge, low grade fever, coughing blood, energy decreased, feels awful and respiratory tract congestion were resolved.   It was unknown if the reporter considered the respiratory syncytial virus infection, sniffles, cough, sneezing, bloody discharge, low grade fever, coughing blood, energy decreased, feels awful and respiratory tract congestion to be related to Shingrix.     It was unknown if the company considered the respiratory syncytial virus infection, sniffles, cough, sneezing, bloody discharge, low grade fever, coughing blood, energy decreased, feels awful and respiratory tract congestion to be related to Shingrix.   Additional Information: GSK Receipt Date: 05-JAN-204 This patient self-reported this case. The patient received Shingrix vaccine approximately in July 2023.  The patient was diagnosed with the Respiratory syncytial virus (RSV) infection on 29th November 2023.  During describing her experiences she stated that she became congested and felt very yucky. She was sniffling, coughing, sneezing, had a low-grade fever and so she was taken to the urgent care.  The symptoms got worse within the week, and she was again in the emergency room (ER) for what felt like a whole day but could not do much She was given her nebulizer treatments and Mucinex.  When she was coughing, mucous and blood was coming up. It was not an alarming amount and the physician confirmed that it was nothing more other than the constant cough and force that was causing the bleeding.  It really zapped her energy. She had to slow down and rest when diagnosed because she could not keep up and just did not have the energy to do anything. She was now back to her normal lifestyle, although with the walking/exercising, she was gradually working up to walking more.  She was given nebulizer treatments, Mucinex for her RSV and already had an inhaler for her Interstitial lung disease (ILD) that she very rarely used prior to being diagnosed.  When the physician confirmed she could use it when she was diagnosed with RSV she would use it 2-3 times a day.  She was unsure of exact name for the rescue inhaler.  The ILD was diagnosed over 6 years ago.